During the past decade, Hapworth Research Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hapworth Research Inc." are "Treatment Resistant Depression" (2 trials), "Autism Spectrum Disorder" (1 trials), "Obsessive Compulsive Disorder" (1 trials), "Obsessive-Compulsive Disorder" (1 trials) and "Tourette Syndrome" (1 trials). Many other conditions were trialed in "Hapworth Research Inc." in a lesser frequency.

Most popular intervention types in "Hapworth Research Inc." are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ecopipam" (2 trials), "Balovaptan" (1 trials), "Troriluzole" (1 trials) and "Troriluzole (BHV-4157)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hapworth Research Inc." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hapworth Research Inc.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Hapworth Research Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hapworth Research Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".